The Mexico cervical cancer screening study trial showed that in women with positive results for HPV16/18 genotyping, the p16/Ki-67 dual-stained cytology test performs better than cytology and E6 oncoprotein in discriminating relevant progressive infections (6). This evidence concerns the gene MKI67 and cervical carcinoma.